Shanghai Hanwei Biomedical Technology Co., Ltd. was established in 2008.Deeply rooted in the field of pet medicine and health in China, Hanwei Chongshi focus on the areas of pet medicine such as anti-infection, skin care, pain relief, urology, ophthalmology, cardiovascular and internal and external deworming, and continuously providing customers with new pet-specific drugs, health care products and professional services. As of January 2025, Hanwei Chongshi has obtained 12 new national veterinary drug certificates, 46 pet drug approval documents, and has developed over 50 pipeline products, becoming the loyal choice of tens of thousands of professional pet hospitals. According to the "2025 China Pet Medicine White Paper" released by Frost & Sullivan, Hanwei Chongshi has the highest offline store coverage rate among domestic pet medicine brands in China.